AURA logo

Aura Biosciences (AURA)

Profile

Full Name

Aura Biosciences, Inc.

Ticker Symbol

AURA

Exchange

NASDAQ

Country

United States

IPO

October 29, 2021

Indexes

Not included

Employees

106

Key Details

Price

$5.30(+6.64%)

Market cap

$266.19M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.75(+9.33% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 26, 25 Citizens Capital Markets
Market Outperform
Mar 25, 25 HC Wainwright & Co.
Buy
Mar 24, 25 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Oct 18, 24 Scotiabank
Sector Outperform
Oct 18, 24 HC Wainwright & Co.
Buy
Oct 18, 24 BTIG
Buy
Sep 13, 24 JMP Securities
Market Outperform
Sep 13, 24 HC Wainwright & Co.
Buy
Aug 28, 24 JMP Securities
Market Outperform

Institutional Ownership

  • What is the ticker symbol for Aura Biosciences?
  • Does Aura Biosciences pay dividends?
  • What sector is Aura Biosciences in?
  • What industry is Aura Biosciences in?
  • What country is Aura Biosciences based in?
  • When did Aura Biosciences go public?
  • Is Aura Biosciences in the S&P 500?
  • Is Aura Biosciences in the NASDAQ 100?
  • Is Aura Biosciences in the Dow Jones?
  • When was Aura Biosciences's last earnings report?
  • When does Aura Biosciences report earnings?
  • Should I buy Aura Biosciences stock now?

What is the ticker symbol for Aura Biosciences?

The ticker symbol for Aura Biosciences is NASDAQ:AURA

Does Aura Biosciences pay dividends?

No, Aura Biosciences does not pay dividends

What sector is Aura Biosciences in?

Aura Biosciences is in the Healthcare sector

What industry is Aura Biosciences in?

Aura Biosciences is in the Biotechnology industry

What country is Aura Biosciences based in?

Aura Biosciences is headquartered in United States

When did Aura Biosciences go public?

Aura Biosciences's initial public offering (IPO) was on October 29, 2021

Is Aura Biosciences in the S&P 500?

No, Aura Biosciences is not included in the S&P 500 index

Is Aura Biosciences in the NASDAQ 100?

No, Aura Biosciences is not included in the NASDAQ 100 index

Is Aura Biosciences in the Dow Jones?

No, Aura Biosciences is not included in the Dow Jones index

When was Aura Biosciences's last earnings report?

Aura Biosciences's most recent earnings report was on Mar 24, 2025

When does Aura Biosciences report earnings?

The next expected earnings date for Aura Biosciences is May 9, 2025

Should I buy Aura Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page